{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:24:51Z","timestamp":1791059091896,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"German Ministry of Education and Research","award":["BMBF 01GM0887"],"award-info":[{"award-number":["BMBF 01GM0887"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.nmd.2013.10.011","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T14:30:28Z","timestamp":1384353028000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Somatropin treatment of spinal muscular atrophy: A placebo-controlled, double-blind crossover pilot study"],"prefix":"10.1016","volume":"24","author":[{"given":"J.","family":"Kirschner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schorling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hauschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rensing-Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Wein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Grieben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Schottmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Schara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"M\u00fcller-Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Wilichowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hobbiebrunken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Stettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Korinthenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8174","key":"10.1016\/j.nmd.2013.10.011_b0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(80)90847-8","article-title":"Classification of spinal muscular atrophies","volume":"1","author":"Pearn","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2013.10.011_b0010","doi-asserted-by":"crossref","unstructured":"Rudnik-Sch\u00f6neborn S, Wirth B, Grimm T, Zerres K. Spinal muscular atrophies (in german). 2000;60\u201391.","DOI":"10.1007\/978-3-642-57043-8_3"},{"issue":"4","key":"10.1016\/j.nmd.2013.10.011_b0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajmg.10425","article-title":"Genetic risk assessment in carrier testing for spinal muscular atrophy","volume":"110","author":"Ogino","year":"2002","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.nmd.2013.10.011_b0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nmd.2013.10.011_b0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/513886","article-title":"Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype","volume":"61","author":"Campbell","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2013.10.011_b0030","article-title":"Drug treatment for spinal muscular atrophy types II and III","volume":"4","author":"Wadman","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.nmd.2013.10.011_b0035","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","article-title":"Childhood spinal muscular atrophy: controversies and challenges","volume":"11","author":"Mercuri","year":"2012","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.nmd.2013.10.011_b0040","first-page":"2877","article-title":"Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults","volume":"82","author":"Johannsson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1152\/jappl.1991.70.2.688","article-title":"Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/jappl.1991.70.2.695","article-title":"Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance","volume":"70","author":"Cuneo","year":"1991","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nmd.2013.10.011_b0055","series-title":"Effects of growth hormone in adulthood (in german) Ludwigs Maximillians University","author":"Strasburger","year":"1999"},{"issue":"5","key":"10.1016\/j.nmd.2013.10.011_b0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tem.2011.02.005","article-title":"Growth hormone and physical performance","volume":"22","author":"Birzniece","year":"2011","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/EJE-10-0009","article-title":"Muscle strength in elderly adults with GH deficiency after 10years of GH replacement","volume":"163","author":"G\u00f6therstr\u00f6m","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.nmd.2013.10.011_b0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1067\/S0022-3476(03)00246-4","article-title":"Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee","volume":"143","author":"Wilson","year":"2003","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.nmd.2013.10.011_b0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0960-8966(01)00193-6","article-title":"Reference values of maximum isometric muscle force obtained in 270 children aged 4\u201316years by hand-held dynamometry","volume":"11","author":"Beenakker","year":"2001","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ptj\/72.2.115","article-title":"Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne\u2019s muscular dystrophy","volume":"72","author":"Florence","year":"1992","journal-title":"Phys Ther"},{"issue":"6","key":"10.1016\/j.nmd.2013.10.011_b0085","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/mus.1070","article-title":"Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children","volume":"24","author":"Escolar","year":"2001","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nmd.2005.11.010","article-title":"Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study","volume":"16","author":"Mercuri","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"9\u201310","key":"10.1016\/j.nmd.2013.10.011_b0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","article-title":"An expanded version of the Hammersmith functional motor scale for SMA II and III patients","volume":"17","author":"O\u2019Hagen","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.nmd.2013.10.011_b0100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.nmd.2012.06.352","article-title":"Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study","volume":"22","author":"Werlauff","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/088307380001500207","article-title":"Prospective analysis of strength in spinal muscular atrophy. DCN\/spinal muscular atrophy group","volume":"15","author":"Iannaccone","year":"2000","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2013.10.011_b0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mus.10166","article-title":"Reliability of hand-held dynamometry in spinal muscular atrophy","volume":"26","author":"Merlini","year":"2002","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.nmd.2013.10.011_b0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/08830738030180080501","article-title":"Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study","volume":"18","author":"Merlini","year":"2003","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy","volume":"14","author":"Mercuri","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2013.10.011_b0125","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/mus.20018","article-title":"Motor function-muscle strength relationship in spinal muscular atrophy","volume":"29","author":"Merlini","year":"2004","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0960-8966(01)00272-3","article-title":"90th ENMC international workshop: European spinal muscular atrophy randomised trial (EuroSMART) 9\u201310 February 2001, Naarden. The Netherlands","volume":"12","author":"Merlini","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"8649","key":"10.1016\/j.nmd.2013.10.011_b0135","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"J\u00f8rgensen","year":"1989","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.nmd.2013.10.011_b0140","first-page":"4570","article-title":"Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults","volume":"84","author":"Woodhouse","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.nmd.2013.10.011_b0145","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1210\/jcem.85.5.6598","article-title":"Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study","volume":"85","author":"Vahl","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.nmd.2013.10.011_b0150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.1997.2801076.x","article-title":"Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3years","volume":"47","author":"Wallymahmed","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.nmd.2013.10.011_b0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1992.tb02901.x","article-title":"Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study","volume":"36","author":"Whitehead","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.nmd.2013.10.011_b0160","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2265.2009.03592.x","article-title":"Impact of GH substitution on exercise capacity and muscle strength in GH-deficient adults: a meta-analysis of blinded, placebo-controlled trials","volume":"71","author":"Rubeck","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.nmd.2013.10.011_b0165","first-page":"313","article-title":"Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes","volume":"128","author":"Deyssig","year":"1993","journal-title":"Acta Endocrinol"},{"issue":"3 Pt. 1","key":"10.1016\/j.nmd.2013.10.011_b0170","first-page":"E261","article-title":"Effect of growth hormone and resistance exercise on muscle growth in young men","volume":"262","author":"Yarasheski","year":"1992","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jcem.87.2.8206","article-title":"GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men","volume":"87","author":"Lange","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.nmd.2013.10.011_b0180","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1532-5415.2001.49173.x","article-title":"Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people","volume":"49","author":"Hennessey","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1016\/j.nmd.2013.10.011_b0185","first-page":"1361","article-title":"Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men","volume":"79","author":"Taaffe","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.nmd.2013.10.011_b0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/edrv-4-2-155","article-title":"Human pituitary growth hormone (hGH) therapy in growth hormone deficiency","volume":"4","author":"Frasier","year":"1983","journal-title":"Endocr Rev"},{"key":"10.1016\/j.nmd.2013.10.011_b0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000316126","article-title":"Safety of recombinant human growth hormone","volume":"18","author":"Carel","year":"2010","journal-title":"Endocr Dev"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613009917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613009917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:01:58Z","timestamp":1760774518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896613009917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0960896613009917"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.10.011","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatropin treatment of spinal muscular atrophy: A placebo-controlled, double-blind crossover pilot study","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}